Dual alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases

Details for Australian Patent Application No. 2004280090 (hide)

Owner KeyNeurotek Pharmaceuticals AG IMTM GmbH

Inventors Striggow, Frank; Nordhoff, Karsten; Tager, Michael; Bank, Ute; Ansorge, Siegfried

Agent Cullen & Co

Pub. Number AU-B-2004280090

PCT Pub. Number WO2005/034940

Priority 103 48 044.7 15.10.03 DE

Filing date 15 October 2004

Wipo publication date 21 April 2005

Acceptance publication date 13 August 2009

International Classifications

A61K 31/404 (2006.01)

A61K 31/4045 (2006.01)

C07C 233/83 (2006.01) Carboxylic acid amides

C07C 243/28 (2006.01) Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes

C07C 251/86 (2006.01) Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

C07C 327/48 (2006.01) Thiocarboxylic acids

C07D 207/327 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 295/15 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 317/58 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/034940 Priority application(s): WO2005/034940

17 April 2008 Alteration of Name

  The name of the applicant has been altered to IMTM GmbH; KeyNeurotek Pharmaceuticals AG

13 August 2009 Application Accepted

  Published as AU-B-2004280090

10 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280091-Filter bag and method for the production thereof

2004280088-1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics